New vaccine aims to train immune system against HPV throat cancer
NCT ID NCT06007092
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a vaccine designed to help the immune system fight HPV-positive throat cancer. It is for patients who have completed surgery or chemoradiation and show no signs of cancer remaining. The trial will enroll 24 adults to find the safest and most effective dose by measuring immune responses and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gustave Roussy
RECRUITINGVillejuif, 94 805, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- Can a simple supplement tame inflammation before cancer surgery?
- FLASH therapy: a flash of hope for head and neck cancer retreatment?
- Can MRI measurements be trusted for head and neck cancer?
- Can a simple fluoride treatment save teeth after cancer radiation?
- Cancer gene hunt: 21,000 Patients' DNA scoured for clues